Assessment of the efficacy and safety of anlotinib for the treatment of recurrent epithelial ovarian cancer
Abstract Objective The current research aims to evaluate the efficacy and safety of anlotinib, an orally administered small-molecular tyrosine kinase inhibitor (TKI), in the treatment of recurrent epithelial ovarian cancer (EOC). Methods Patients with recurrent EOC subjected to treatment with anloti...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer
2024-08-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01267-8 |
| Tags: |
No Tags, Be the first to tag this record!
|